[Prognosis of inoperable bronchial carcinomas managed through a combination of cytostatic- and radiotherapy].
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D001317:Austria; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011033:Podophyllin / Q000627:therapeutic use; D011379:Prognosis; D011879:Radiotherapy Dosage; D012075:Remission, Spontaneous
D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide; D011033:Podophyllin
Prognose kombiniert zytostatisch-radiologisch behandelter inoperabler Bronchuskarzinome